United States · FDA National Drug Code directory
TIMOLOL MALEATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-325_b6fecc68-5e40-4191-a365-568ccedf0697
- Product NDC
- 69315-325
- Form
- SOLUTION
- Composition / generic term
- TIMOLOL MALEATE
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241107
- Source listing expiry
- 20261231
Source-listed ingredients
- TIMOLOL MALEATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 BOTTLE, PLASTIC (69315-325-05) · 69315-325-05
- 10 mL in 1 BOTTLE, PLASTIC (69315-325-10) · 69315-325-10
- 15 mL in 1 BOTTLE, PLASTIC (69315-325-15) · 69315-325-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →